We previously reported that the Ets1 transcription factor is expressed in endothelial cells during angiogenesis both in normal and pathological development. We analyse here the eects of the stable expression of an Ets transdominant negative mutant (Ets1-DB), consisting in an Ets1 protein lacking its transactivation domain. A retrovirus containing the Ets1-DB sequence fused to an IRES-Neo sequence was designed and used to infect brain capillary (IBE) and aorta (MAE) mouse endothelial cell lines. Cells expressing this Ets1 mutant were examined for proliferation, migration and adhesion. Consistent changes were observed on cell morphology, with increased spreading and modi®cations in the organization of the cytoskeleton, and increased cell adhesion. We investigated the ability of endothelial cells to organise into capillary-like structures using three-dimensional gels. On Matrigel, all endothelial cell lines formed a cord-like network within 24 h, with an increased ability of Ets1-DB cells to spread on this substrate. In long term cultures, IBE cells expressing Ets1-DB showed a higher capacity to form branched structures; this eect was potentiated by FGF2. These results demonstrate a role of the Ets transcription factors in the regulation of the adhesive and morphogenetic properties of endothelial cells. Oncogene (2000) 19, 762 ± 772.
Introduction
Ets1 is the cellular progenitor of the v-ets oncogene found in the genome of the avian leukaemia retrovirus E26. Ets1 encodes a transcription factor which is the founder of a family containing more than 30 related proteins, identi®ed in species ranging from Caenorhabditis elegans to human (reviewed in CreÂ pieux et al., 1994; Ghysdael and Boureux, 1997) . The signature of this family is a 85 amino acids sequence, which corresponds to the DNA-binding domain. Indeed this domain confers the ability to recognise a sequence containing a purine rich core motif GGAA/T, also named the Ets binding site. Functional Ets binding sites have been identi®ed in various cellular promoters (reviewed in Ghysdael and Boureux, 1997) , including the promoters of genes encoding transcription factors such as JunB, growth factor receptors such as VEGFR-1 (Wakiya et al., 1996) , Tie-1 and Tie-2 Iljin et al., 1999) , matrix degrading proteases and their inhibitors (Gum et al., 1996; Logan et al., 1996) and adhesion molecules such as b2 integrin, ICAM and VE-cadherin (Bottinger et al., 1994; de Launoit et al., 1998; Gory et al., 1998) .
The Ets1 gene is not ubiquitously expressed in embryonic and adult tissues. Rather, we and others previously evidenced the speci®c expression of Ets1 during invasive processes, including the formation of new blood vessels during normal and pathological development (reviewed in Vandenbunder et al., 1995) . In embryos, Ets1 is expressed in the blood islands of the yolk sac where are located the hemangioblasts, the precursors of the hematopoietic and vascular lineages, and in endothelial cells (Pardanaud and DieterlenLieÁ vre, 1993; Vandenbunder et al., 1989) . This expression is detected in endothelial cells during both vasculogenesis and angiogenesis. In adults, Ets1 is expressed in endothelial cells during wound healing, tumour angiogenesis, and during re-endothelialization after denuding injury (Bolon et al., 1995; Wernert et al., 1992 Wernert et al., , 1994 . In agreement with its expression during new blood vessel formation but not in mature vessels, ets1 mRNA expression was found to be higher in proliferating but not in con¯uent human endothelial cells (Wernert et al., 1992) . Ets1 mRNA levels have been shown to be increased upon treatment with angiogenic factors, such as TNFa, PMA, FGF, and VEGF (Chen et al., 1997; Iwasaka et al., 1996; Wernert et al., 1992, and our unpublished data) . These results suggest that Ets1 can be involved in angiogenesis associated with normal development and tumour growth. Recently, Ets1 de®cient mice have been obtained by homologous recombination (Barton et al., 1998) . Although no detailed description of their vasculature has been published, the existence of viable ets17/7 mice suggests that Ets1 is not essential for blood vessel formation in the embryo. Redundancy between Ets family members may account for this result, since the expression pattern of Ets1 overlaps the patterns of Erg and Fli, but not of Ets2, in endothelial cells during early embryonic development (Dhordain et al., 1995; Grevin et al., 1993; Maroulakou et al., 1994; Vandenbunder et al., 1989 ).
An ecient approach to investigate the role of Ets family members in endothelial cells is to analyse the consequences of the cellular expression of an Ets transdominant negative mutant. This strategy has been successfully used in ®broblasts and epithelial cells. Indeed Ets1, Ets2 and PU.1 mutant proteins lacking their transactivation domain can reverse Ras transformation in NIH3T3 cells (Foos et al., 1998; Langer et al., 1992; Wasylyk et al., 1994) . A similar Ets1 mutant inhibits mammary epithelial cell invasion (Delannoy et al., 1998) . In addition, mutants of Ets2 were found to abolish anchorage-independent growth and CSF1-stimulated invasion by breast carcinoma cells (Sapi et al., 1998) . In the present study, we designed replication defective MFG retroviruses containing the sequence of an Ets transdominant negative mutant (Ets1-DB). These retroviral vectors allowed us to eciently infect brain capillary (IBE) and aorta (MAE) mouse endothelial cells and select lines stably expressing the Ets1-DB protein. We then examined the eects of this Ets1 mutant on endothelial cell proliferation, migration and adhesion and on their ability to form capillary-like structures in vitro.
Results

Vector constructions and functional characterization
We designed a cDNA encoding a Ets1-DB protein, containing the 78 amino-acids DNA binding domain of Ets1 and the presumed nuclear transport signal (Boulukos et al., 1989) , without the C-terminal inhibitory region of Ets1 (Hagman and Grosschedl, 1992 ). An IRES sequence was used in order to translate both the Ets1-DB and neomycin-resistance proteins from a single viral mRNA. This Ets1-DB-IRES-Neo sequence was inserted into a MFG retroviral vector, and named MFG-DB. A second vector (MFG-Neo) carrying the IRES and Neo sequences was constructed and used as a control throughout this study (Figure 1) .
The recombinant Ets1-DB protein was produced using an in vitro translation system, and its binding to a 32 P-labelled double stranded oligonucleotide containing an Ets-binding site (EBS) was assayed by electromobility shift (Figure 2a ). This binding was competed for by a 250-fold excess of unlabelled probe, but not by a 250-fold excess of unlabelled non-speci®c DNA. The Ets1 mutant increases endothelial cell adhesion V Mattot et al addition of an anti-Ets1-DB antibody prevented the Ets1-DB/EBS probe complex from entering the gel. Therefore, the Ets1-DB protein binds speci®cally and reversibly to an EBS sequence, and the complex is recognized by a speci®c anti Ets1-DB antibody.
The ability of the Ets1-DB protein to inhibit the transcriptional activation of promoter elements containing Ets binding sites was assessed by transient transfection experiments in NIH3T3 ®broblasts ( Figure  2b ). As expected, the transactivating eect of Ets1 was nearly completely inhibited in a dose-dependent manner by co-transfection with the MFG-DB plasmid, while transactivation of the control pCH110 (bgal) vector was aected neither by Ets1, nor by the Ets1-DB mutant (Figure 2b ). Similar eects were obtained in IBE and MAE endothelial cells, but the very low eciency of transfection (less than 5% compared to 20 ± 30% in NIH3T3) did not allow a proper quanti®cation of these results. We have shown that the stable expression of this Ets1-DB mutant in mammary epithelial cells eciently inhibited the expression of the urokinase-type plasminogen activator (u-PA) gene whose promoter contains functional Ets-binding sites (Delannoy et al., 1998) .
Endothelial cell infection and functional expression of the Ets1-DB protein
Packaging GP+E86 cells were transfected with the MFG retrovirus constructs in order to produce recombinant ecotropic retroviruses. Cells were selected for neomycin resistance and subsequently assayed for virus production. The viral titre estimated by infection of NIH3T3 was higher than 10 6 cfu/ml for each virusproducing cell line (data not shown). Two viral transcripts corresponding to the unspliced and spliced RNAs were expected, since the recombinant constructions were cloned downstream the splice site of the MFG virus (Figure 1 ). Expression of these two transcripts in GP+E86-MFG-Neo or -MFG-DB cell lines was detected by Northern-blotting using an IRESNeo or an ets1 probe (data not shown). Immunoprecipitation experiments showed that GP+E86-MFG-DB cells expressed the Ets1-DB protein, with an expected apparent molecular weight of approximately 13 kDa, recognised by the anti-Ets1-DB antibody (data not shown).
IBE and MAE mouse endothelial cells were infected with viral supernatants obtained from these GP+E86 cells. The high eciency of infection with the MFG retrovirus (*80%) allowed us to generate rapidly Neo-and DB-endothelial cell lines after selection with G418. Rather than selecting individual clones, we took advantage of the fact that most endothelial cells acquired the gene upon infection to generate these cell lines. Consequently, the eect of the Ets1-DB protein could be observed independently of the integration site of the provirus. Following their generation, IBE-Neo, IBE-DB, MAE-Neo and MAE-DB cell lines were checked for viral mRNA expression (data not shown) and recombinant Ets1-DB protein expression ( Figure  3 ). This procedure of infection was repeated several times during the course of the experiments, to generate independent endothelial cell lines expressing or not the Ets1-DB mutant, and the biological eects described below were consistently obtained.
Eects of the Ets1-DB on endothelial cell proliferation and spreading
The proliferation rates of the four infected cell lines were similar along the routine culture process, suggesting that the expression of Ets1-DB did not aect endothelial cell proliferation. In order to substantiate this observation, we performed cell proliferation assays. Both MAE and IBE cell lines showed a classical growth curve. The rate of growth of Ets1-DB cells was equivalent to that of Neo cells, and also similar for non-infected endothelial cells, excluding a potential side eect of the viral infection ( Figure 4 ). The IBE and MAE cell lines showed cell contact inhibition and the cell number reached a plateau at 1.10 6 cells/well and 7.10 5 cells/well, respectively, after 7 days.
Since the initial retroviral infection, we noticed a change in the morphology of the Ets1-DB endothelial cells when compared to the control endothelial cell lines. IBE-control (data not shown) and -Neo cells ( Figure 5 ; see also Figure 7 ) had a roughly triangular shape and were elongated, whereas IBE-DB cells spread and¯attened. In addition, the contours of IBE-control and -Neo cells were regular, whereas IBE-DB cells presented more lamellipodia at their periphery ( Figure 5 ). Wild type MAE cells are larger and spread more than IBE cells. Similarly to IBE-DB cells, MAE-DB cells appeared to spread and to¯atten more than MAE-control (data not shown) and -Neo cells ( Figure  5 ). These morphological dierences were still visible ( Figure 5 ) when the MAE or IBE cell lines reached con¯uence, and they disappeared after a few days (data not shown).
Eects of Ets1-DB on endothelial cell adhesion
The increased ability of DB-endothelial cell lines to spread suggested that they had increased adhesion properties. Endothelial cells expressing the Ets1-DB protein were checked for adhesion on plastic, laminin, type I collagen and ®bronectin ( Figure 6 ). In preliminary experiments we established that most of the cells attached within 1 h and that a 10 min timepoint gave optimal conditions for the analysis of their relative adhesion properties.
Overall, IBE cells adhered better onto ®bronectin and laminin than onto collagen I and plastic ( Figure  6a ). In agreement with their increased spreading ability, IBE-DB cells adhered better than IBE-Neo cells onto plastic, laminin, collagen I and at low concentrations of ®bronectin ( Figure 6a ). On laminin, the dierential eect was more evident at 1 mg/well, with 44% of IBE-DB cells attached compared to 21% of IBE-Neo cells. At higher laminin concentration (20 mg/well), the percentage of attached IBE-Neo and -DB cells was almost identical (64 and 68%, respectively). This dose-dependent eect was also observed using type I collagen or ®bronectin as a substrate.
The adhesive properties of MAE were similar to those of IBE cells, with a greater ability for MAE cells to attach onto type I collagen (compare Figure 6a ,b). As observed with IBE cells, MAE-DB cells attached more eciently than MAE-Neo cells onto the various substrates at low concentration ( Figure 6b ). The eciency of the Ets1-DB to promote cell adhesion was more obvious at the lowest concentration of laminin tested (0.5 mg/well): MAE-DB cells had a fourfold greater ability to adhere to this substrate than MAE-Neo cells.
Eects of Ets1-DB on cytoskeleton re-organization
The distribution of the actin network and focal contacts was examined in endothelial cell lines grown on laminin, on which we evidenced the greatest ability Figure 5 Morphology of Neo-and DB-endothelial cells. Cells were seeded at low density onto gelatin (MAE) and gelatin®bronectin (IBE) coated dishes and photographed the next day. The morphology of the cells after con¯uency is shown in the lower panels (bar: 50 mm)
Ets1 mutant increases endothelial cell adhesion V Mattot et al of Ets1-DB to promote cell adhesion. Cells were double-labelled with rhodamine-phalloõÈ din and with an antibody directed against vinculin, an intra-cellular component of focal contacts.
IBE-DB cells exhibited actin stress ®bres extending along the axis of the cell and these micro®lament bundles were parallel to each other (Figure 7 ). In contrast, IBE-Neo cells showed a more diuse distribution of micro®laments and only short micro®laments bundles were present (Figure 7) . Vinculin was detected in IBE-DB cells, in rod-like structures localized throughout the entire cell area. In IBE-Neo cells (Figure 7) , vinculin was mostly detected at high magni®cation (data not shown) in rod-like structures located preferentially at the periphery of cells and in particular in the most proximal regions of lamellipodia. Actin ®laments converged towards these rod-like structures, which are the focal contacts localized at the basal side of the cells. The number of these focal contacts was evaluated by counting these rod-like vinculin containing structures: 106+34 and 149+54 focal contacts in IBE-Neo and -DB cells (n=10), respectively.
Similarly, actin was organised in MAE-DB cells in numerous long micro®lament bundles that crossed the whole cell, whereas in MAE-Neo cells actin formed short micro®lament bundles and the micro®laments appeared more randomly arranged (Figure 7 ). In these cells, vinculin appeared homogeneously distributed, albeit the number of rod-like structures appeared greater in MAE-DB than in MAE-Neo cells ( Figure  7 ). The number of focal contacts was 143+44 and 315+114 respectively in MAE-Neo and -DB cells (n=10). Eects of Ets1-DB on cell migration and on the formation of capillary-like structures
The migration and morphological dierentiation of endothelial cells is known to be dependent on the composition of the extracellular matrix (Kubota et al., 1988) . We ®rst investigated the consequences of Ets1-DB expression on endothelial cell migration onto several ECM substrates. MAE or IBE cells were assayed for overnight migration through porous membranes coated with laminin, ®bronectin, type I and type IV collagen or Matrigel, in migration chambers. Within this time-period, there was no major dierences in cell migration between cells expressing Ets1-DB and control cells, albeit MAE-DB cells migrated slightly faster than MAE-Neo cells through laminin-and type I collagen-coated membranes (data not shown). No major dierences were also observed when the motility of infected cells was measured after wounding of a con¯uent monolayer with a razor blade, or with a 6 mm diameter Whatman 3MM paper disk (Klein-Soyer et al., 1986) (data not shown).
The ability of endothelial cells to form capillary-like structures was examined on Matrigel, a basement membrane extract (Figure 8) . Within 1 h, individual cells attached onto the gel and were homogeneously distributed; after a few hours, they became fusiform, with budding cellular extensions. After 18 h, IBEcontrol or IBE-Neo cells had migrated and organized into a network of cord-like structures connecting compact cell clusters. Although the general organization of IBE-DB was similar, these cells aligned and spread onto the gel forming ribbon-like structures connecting scattered clusters in which each individual cell was clearly visible after staining. Similar results were obtained with MAE cells (Figure 8) .
After 48 h, these cell clusters grew in size and most connections between them disappeared (Figure 9 ). The following days, sprouts emerged from the cell clusters; these extensions were more abundant from IBE-DB than from IBE-Neo cell clusters. Within 10 days, these capillary-like structures grew, branched, and invaded the gel. In contrast the IBE-Neo cell clusters remained compact, with minor sprouting (Figure 9 ). Branching morphogenesis was not observed in MAE cells. Both MAE-Neo-and DB-a cells developed as aggregates surrounded by numerous scattered cells, which were aligned in several instances.
In previous experiments, endothelial cells were seeded onto the gel. When mixed with Matrigel before seeding and cultured for several days, Neo-and DB-cells behaved similarly (data not shown); in particular both IBE cell lines grew as compact structures. We then cultured the cells after mixing them with Matrigel: type I Collagen (1 : 1 ratio), which favours branching morphogenesis (unpublished data). After 9 days of culture in this gel, sprouting and branching was observed from IBE-DB cells, but not from IBE-Neo cells (Figure 10 ). Interestingly, this behaviour of IBE-DB cells mimicked the response of IBE-Neo cells to FGF2 (10 ng/ml). We found that the expression of the Ets1-DB mutant enhanced the sprouting and the branching eects of FGF2. In Matrigel : collagen gels, MAE cells did not grow as cell clusters like IBE cells; rather they dispersed in the gel and were also able to align. In agreement, with the results obtained on Matrigel gels (Figure 9 ), no obvious dierences of morphological responses were obtained between MAE-DB and MAE-Neo cells. In addition, no obvious responses to FGF-2 were observed ( Figure 10 , bottom panels).
Discussion
We have examined the eects of the constitutive expression of an Ets1-DB mutant on the cellular functions of two endothelial cell lines. Both the brain capillary (IBE) cells and normal aortic (MAE) endothelial cells expressing the Ets1-DB protein exhibited extended spreading ability, that was accompanied by changes in cytoskeleton organization and increased adhesive properties. No obvious modi®cations of cell proliferation or migration were observed. In three-dimensional cultures the behaviour of both cell lines was distinct. The IBE cells expressing Ets1-DB showed a higher capacity to form a network of branched structures compared to IBE-Neo cells, whereas both MAE cell lines behave similarly. These data are the ®rst demonstration that Ets family members are involved in the regulation of endothelial cell adhesion, which can lead to a modi®cation of their morphogenetic properties.
Two initial observations led us to examine the adhesion properties of endothelial cells expressing the Ets1-DB mutant. First, the Ets1-DB cells consistently took longer than control cells to detach from the culture dishes when treated with trypsin/EDTA, suggesting that the adhesion of the Ets1-DB cells was stronger than that of control cells. Second, IBE-DB and MAE-DB cells were found to be enlarged and Figure 8 Short term morphogenesis assay of Neo-and DBendothelial cells on Matrigel. Neo-, or DB-endothelial cells were cultured on Matrigel. After 18 h, IBE-Neo cells had migrated towards each other and formed a network of branching cord-like structures connecting compact cell clusters. IBE-DB cells formed a similar network, albeit the spreading ability of these cells was clearly increased (compare -DB with non infected control and -Neo cells). They organized into more scattered cell clusters in which each endothelial cell could be easily identi®ed due to an increased spreading onto the substrate; after staining, the nucleus and cytoplasm of cells were clearly distinguishable. After 18 h, the organization of MAE-Neo cells on Matrigel was similar to the organization of IBE-control or IBE-Neo cells. An increased spreading was also observed with MAE-DB cells compared to MAE-Neo cells (bar : 130 mm)
Ets1 mutant increases endothelial cell adhesion V Mattot et al ¯attened compared to their respective control cell lines. These modi®cations were conspicuous at low density and persisted until con¯uence. In parallel, we found that the adhesion properties of IBE-and MAE-DB cell lines were increased on plastic, laminin, type I collagen, at low concentrations of ®bronectin and on Matrigel. The dose response eects suggest either an increase in adhesion receptor number or in their relative anity for the matrix molecules. Since IBE-and MAE-DB cells no longer attached onto the various substrates tested in the absence of calcium and magnesium in the medium (data not shown), their adhesion was most probably mediated by integrin receptors (reviewed in Gumbiner, 1996) . No dierences between control and Ets1-DB endothelial cells were observed on the accumulation of the a6 or b1 integrin mRNAs subunits, an a6b1 integrin that mediates cell adhesion almost exclusively onto laminins (Hall et al., 1990; Hierck et al., 1996; Kramer et al., 1990) . We also found that expression of av integrin subunit, which is involved in angiogenesis both by its expression and by experiments aiming to block its activity (Brooks et al., 1994a,b) , was not aected by the expression of the Ets1-DB mutant (data not shown).
The modi®ed adhesion properties correlate with a change in the distribution of cytoskeleton components. Vinculin, an intra-cellular link between integrin adhesion receptors and the cytoskeleton (reviewed in Jockusch et al., 1995) , was distributed in the whole area of cells expressing Ets1-DB, whereas it was distributed preferentially in lamellipodia of control endothelial cells. Therefore it is possible that Ets1-DB disturbed the expression of a protein that modify integrins distribution, their association at the cell surface and subsequently their anity. Alternatively, since Ets1-DB expression resulted in an overall greater adhesion ability, it may have disturbed the expression of extra-cellular proteins such as thrombospondin-1, tenascin or SPARC that modulate cell-matrix interactions (Sage and Bornstein, 1991) . In agreement with our results, several lines of evidence indicate that Ets family members take part in the transcriptional regulation of cell adhesion in dierent cell types. Thus, Ras-transformed NIH3T3 cells expressing the DNA binding domain of PU.1, Ets1 or Ets2 are larger and¯atter, and adhere better to plastic than control cells (Foos et al., 1998; Wasylyk et al., 1994) . The overexpression of Fli during embryogenesis in the Xenopus results in a lack of adhesion between cell separating embryonic layers and in the disorganization of endothelial cell monolayers (Remy et al., 1996) .
These modi®ed adhesion properties could result in changes in migration, since this process implies the formation of new attachments with the extra-cellular matrix at the cell front and their destabilization at the rear. No clear dierences were observed between the Figure 9 Long term morphogenesis assay of Neo-and DB-endothelial cells on Matrigel. 48 h after the onset of the culture on Matrigel, cell clusters were no longer connected. After 3 days, cell sprouting had started around the edges of IBE-DB cell clusters, in all directions on the surface of the gel; limited sprouting occurred with IBE-Neo cells. After 7 days, secondary branches with IBE-DB cells started to extend in the gel, whereas minor sprouting was observed from IBE-Neo cell clusters. After 10 days, cell clusters initially formed by IBE-DB cells at day 2 had completely disappeared and formed a network of homogeneously distributed and well de®ned capillary-like structures which had invaded the gel in all directions. With IBE-Neo cells, aside from an increase in size, cell aggregates had remained compact and minor sprouting and branching was visible. MAE cells did not form such capillary-like structures. Rather MAE-Neo cells formed clumps with few cells emerging at the periphery, whereas MAE-DB cells formed less compact clumps surrounded by numerous scattered cells. Living cells were viewed with a Zeiss Axiovert microscope equipped with Homan contrast (bar: 50 mm)
Ets1 mutant increases endothelial cell adhesion V Mattot et al migration rates of the Ets1-DB and control cells (data not shown). In contrast to our results, Ets1 antisense oligonucleotides have been found to inhibit EGF-or FGF-induced migration (Iwasaka et al., 1996) and VEGF-induced invasion of human endothelial cells (Chen et al., 1997) . This reduced ability of endothelial cells to migrate was further correlated with a reduced expression of the u-PA gene, a putative target of Ets1 (Chen et al., 1997; Iwasaka et al., 1996) . Upon transfection with a murine Ets1 cDNA in a sense or antisense orientation, endothelial cell lines expressing respectively high or low levels of Ets1 have been obtained (Oda et al., 1999) . The invasiveness was enhanced in high Ets1 expression cells, and reduced in low Ets1 expression cells, but the expression of u-PA mRNAs was reportedly similar in both cell lines. In our conditions Northern blot analysis reveals that the expression of Ets1-DB did not change the amount of u-PA mRNAs both in MAE and IBE cells (data not shown). Discrepancies between these results might re¯ect the dierences between the strategies used (speci®c blockade of Ets1 expression versus expression of a transdominant negative mutant of Ets family members) or between the origin of the cells used in these studies. The behaviour of endothelial cells cultured in the presence of Matrigel, a reconstituted gel composed of basement membrane proteins, was found to be modi®ed by the expression of Ets1-DB. Both IBE-DB and MAE-DB cells showed increased spreading after 18 h on Matrigel. Within 10 days, IBE cells expressing Ets1-DB showed a higher capacity to form branched structures by sprouting. Branching morphogenesis requires dynamic changes in cell adhesion, involving the disruption of cell to cell contacts and the reorganization of cell to extra-cellular matrix contacts (Gumbiner, 1996) . However, it cannot be excluded that this process, observed in three dimensional gels, also involves changes in endothelial cell proliferation and migration, that we could not evidence in classical proliferation and migration assays. A further stimulation of sprouting and branching morphogenesis was observed in Matrigel : collagen when FGF2 was added to IBE-DB. Interestingly FGF2 as well as VEGF and other angiogenic factors stimulate the expression of Ets1 and Erg in endothelial cells grown in two dimensions (Chen et al., 1997; Iwasaka et al., 1996; Wernert et al., 1992) . Altogether these results suggest that both negative and positive regulators of endothelial cell morphogenesis may exist within the Ets family and that Ets1-DB does not block all the FGF2 signalling pathways in IBE cells grown in threedimensional gels.
MAE-DB cells also showed changes in cell adhesion, but the expression of Ets1-DB did not result in a clear eect on their morphogenetic properties. The extended structures elaborated from cell clusters consisted mainly in dispersed cells, able to align in several instances, whereas IBE cells were able to form branched structures. It is worth noting that, in a comparative study between MAE cells of aortic origin and murine endothelial cell lines derived from Figure 10 The response to FGF2 of Neo-and DB-cells cultured in a gel composed of Matrigel and type I collagen. IBE or MAENeo and -DB cells were dispersed in a mixture of Matrigel and type I collagen, in the absence (C) or presence of 10 ng/ml FGF2 (FGF2), and viewed after 9 days. Cells were stained with the thiazine dye (stain solution II from the Di-Quick staining kit, Dade) and were viewed either with a Wild Leitz M420 stereomicroscope (black bar: 100 mm) or with a Zeiss Axiovert microscope equipped with Homan contrast (white bar: 50 mm)
Ets1 mutant increases endothelial cell adhesion V Mattot et al capillaries, only the latter have been found to be able to form capillary-like structures in three-dimensional ®brin gels (Bastaki et al., 1997) .
In the present study, we did not address directly the question of the speci®city of the Ets transdominant negative mutants. It has been found previously that the eects of Jun and Ets transdominant negative mutants (Wasylyk et al., 1994) were largely similar, suggesting that they are on the same pathway. Nonetheless, the revertants clones had a distinct morphology, indicating that Ets and Jun can have both shared and divergent functions (Wasylyk et al., 1994) . Within the Ets family, the fact that Ets proteins bind to similar sequences centred over a GGAA/T core motif makes it likely that high level expression of the Ets domain inhibits the binding and function of many members of the Ets family. This idea is supported by the ®nding that expression of the Ets domain of the most divergent Ets family members, Ets1 or Pu-1, could reverse Ras transformation in ®broblasts in a similar manner (Wasylyk et al., 1994) . Experiments with Ets1-DB does not allow the identi®cation of the individual Ets family members which are actually important in a particular cell type; in endothelial cells, together with Ets1, Erg and Fli are also expressed (Dhordain et al., 1995; Vandenbunder et al., 1989) . In addition, two other levels of complexity should be considered for understanding the function of Ets1-DB. The activity of Ets1 mutants lacking the transactivation domains can be mediated by protein ± protein interaction, independently of DNA binding (Sieweke et al., 1998) . In addition, although most Ets factors are transcriptional activators, several widely expressed Ets proteins including Erf, Sap2/Net and Tel have been reported to be negative regulators of transcription (reviewed in Ghysdael and Boureux, 1997) . Therefore the expression of the Ets1-DB can lead to the transcriptional activation of speci®c target genes, and the morphological changes observed may result from a shift in the balance between activators and inhibitors of endothelial cell morphogenesis. At present, our attempts to identify these target genes in endothelial cells were unsuccessful and will require a more systematic study.
Taken together our data suggest that Ets family members are involved in the adhesion and in the morphogenetic properties of endothelial cells that are essential for capillary formation in vivo.
Materials and methods
Cell culture
Murine brain capillary endothelial cells (IBE cells) are derived from the brains of newborn transgenic mice expressing a temperature-sensitive variant of SV40 large T (Kanda et al., 1996) . Murine aortic endothelial cells (MAE cells) are derived from normal mice (Auerbach, 1991) . Virus packaging cells were the murine ®broblasts GP+E86 (Markowitz et al., 1988) . GP+E86, NIH3T3 ®broblasts and MAE cells were cultured at 378C in Dulbecco's modi®ed Eagle's medium (DMEM), containing 10% (heat-inactivated) calf serum (Hyclone) and antibiotics. IBE cells were cultured at 338C, in DMEM containing 20% heat-inactivated calf serum, antibiotics, 20 U/ml g-interferon (Genzyme) and 0.1 ng/ml human recombinant FGF-2 (R&D Systems). Except when mentioned, GP+E86, MAE and IBE cells were cultured on tissue culture dishes, gelatin-coated tissue culture dishes (0.1%, w/v), and both gelatin-(0.1% w/v) and ®bronectin-(10 mg/ml) coated tissue culture dishes, respectively.
Cloning
The cDNA sequence encoding the mouse Ets1 DNA-binding domain (corresponding to amino acids 306 ± 423) was obtained by PCR ampli®cation of mouse Ets1 cDNA (Chen, 1990) with the following pair of primers: 5'-ATC TCG AGA CCA TGG ACT ATG TGC GTG ACC GT and 5'-ATC AAT TGT CTA TCC CAG CAG GCT CTG CAG. The Internal Ribosome Entry Site (IRES) and the neomycinresistance gene were excised from the pCITE vector (Novagen) using EcoRI/BamHI sites. The Ets1 ampli®ed products digested with XhoI/MunI, and the IRES-Neo fragment were ligated to XhoI/BamHI digested pBlueScript SK+(pBS) plasmid (Stratagene). The resulting vector carries the Ets1-DB in front of the IRES sequence and the neomycin resistance gene. Both strands of the Ets1-DB were sequenced. The Ets1-DB-IRES-Neo and the IRES-Neo inserts were then excised from the pBS plasmid and cloned into the NcoI/ BamHI sites of the retroviral MFG vector in replacement of the Gag-Pol-Env genes, according to Drano et al. (1993) .
Virus production and infection of endothelial cells GP+E86 cells were seeded at 150 000/10 cm 2 dishes. The next day, cells were transfected using 2 mg of MFG plasmid and 12 mg of lipofectamine (Gibco) in 1 ml of Optimem for 6 h. This medium was then replaced by the regular culture medium and selection was started 48 h after transfection by the addition of 0.8 mg/ml G418 (Gibco). Viral particles were collected by culturing sub-con¯uent GP+E86 cells in 78.5 cm 2 dishes in 5 ml fresh medium overnight. The medium was then ®ltered (0.45 mm) and used for infection. Viral titration were performed by infecting mouse NIH3T3 ®broblasts with serial dilutions of this medium and counting the number of G418-resistant NIH3T3 clones obtained after 7 ± 10 days.
IBE and MAE cells (150 000/10 cm 2 dish) were incubated for 6 h with 1 ml of virus-producing GP+E86 cell supernatant containing 4 mg/ml of polybrene (Aldrich). Selection started 2 days after, by the addition to the culture medium of 0.5 mg/ml and 0.8 mg/ml of G418, respectively for IBE and MAE cells. After 10 days, cell colonies were pooled and further studied. All experiments were at least duplicated with independent transfections of GP+E86 cells and infections of endothelial cells.
In vitro translation and electromobility-shift assay
One mg of pBS Ets1-DB-IRES-Neo plasmid was mixed with 16.5 ml of rabbit reticulocyte lysate mix (Promega) containing 20 mCi 35 S-methionine (1000 Ci/mmole, ICN) and 25 units of T3 polymerase in a ®nal volume of 25 ml, and incubated for 2 h at 308C. After electrophoresis on 15% SDS-polyacrylamide gels, translation products were visualized by autoradiography. Electromobility-shift assay were performed as described (Soudant et al., 1994) using the synthetic 32 Plabelled 5'-GAT CTT CGA AAC GGA AGT TCG AG double-stranded oligonucleotide.
Transactivation assays
NIH3T3 cells (150 000 cells) were seeded on 10 cm 2 culture wells and cultured overnight. Cell cultures were rinsed once with OptiMEM and co-transfected with or without 250 ng pcDNA-TagETS1, 250 ng TORU-Luc (3xpyRRE-tk-Luc in (Fafeur et al., 1997) , 250 ng pCH110 (bgal from Amersham Ets1 mutant increases endothelial cell adhesion V Mattot et al Pharmacia) reporter vectors and the indicated amount of pMFG-ETS1-DB. Reporter activities were measured 48 h later using the luciferase assay system (Promega) and the Galacto-Light kit (Tropix).
Immunoprecipitation
Cells (150 000 cells/78.5 cm 2 dish) were cultured for 24 h. The medium was then replaced by methionine-and cysteine-free modi®ed Eagle's medium (MEM) and the cells cultured for 2 h. Cells were then incubated for 3 ± 4 h in 3 ml of methionine-and cysteine-free MEM containing 250 mCi 35 Smethionine and -cysteine (Tran 35 S-Label 1066 Ci/mmol, ICN), lysed and the cell extract prepared and used for immunoprecipitation as described (Gilles et al., 1996) .
Actin ®laments staining, and vinculin detection
Glass coverslips (14 mm diameter) were placed into 1.9 cm 2 4-wells culture dishes (Nunclon), incubated with 2 mg laminin (Becton-Dickinson) in 0.5 ml DMEM during 30 min at 378C. Cells (40 000 cells/ 0.5 ml culture medium) were seeded onto the coverslips and cultured overnight. The following staining procedures were performed at room temperature. Culture medium was removed, the cells ®xed with 0.5 ml PHEMS (25 mM HEPES, pH 6.9, 60 mM PIPES, 0.15 M NaCl, 2 mM MgCl 2 , 10 mM EGTA) containing 4% paraformaldehyde, for 10 min and permeabilized in PBS-0.25% Triton X100 for 5 min. Cultures were then incubated in PBS, 3% BSA for 2 h. A monoclonal anti-human vinculin showing good reactivity with mouse vinculin (Sigma V9131, used at 1 : 400 dilution) was added, except to control samples, and the coverslips incubated overnight. After three 0.5 ml washes in PHEMS, the coverslips were incubated in PBS-3% BSA (Sigma) containing 0.8 u/ml Bopidy phalloõÈ din 558/568 (Molecular probes) and a FITC-conjugated goat anti-mouse IgG antibody (1 : 100 dilution, Sigma). The coverslips were incubated for 90 min in the dark, washed three times with 0.5 ml PHEMS, mounted on a microscope slide using Prolong antifade mounting medium (Molecular probes). The number of adhesion contacts was counted by using mathematical morphology tools from the Visilog software (Noesis).
Proliferation assay
IBE and MAE cells were seeded at 9500 cells/4.5 cm 2 wells and 12 000 cells/4.5 cm 2 wells, respectively, cultured for the indicated time, collected with a 0.1% trypsin/EDTA solution and counted with a Coulter counter.
Adhesion assay
Bacteriological plastic 24-well plates (Polylabo) were coated by incubation for 2 h at 378C with 0.3 ml DMEM containing the indicated amount of laminin (Becton-Dickinson), type I collagen (Upstate Biotechnology) or ®bronectin (Sigma). The wells were then incubated for 30 min at 378C or 338C in 0.3 ml MEM containing 3% BSA (w/v), rinsed once with MEM/0.02% BSA and immediately used. Con¯uent MAE or IBE cells were harvested using a 0.1% trypsin/EDTA solution, collected in culture medium, counted, washed three times in DMEM by centrifugation at 500 g for 10 min and ®nally resuspended in DMEM/0.02% BSA. Cells were transferred to the coated wells (100 000 cells/0.5 ml/well) and allowed to adhere for 10 min. The cell supernatant was collected and trypsin/EDTA (0.1%) was added in order to recover the adherent cells. Both non-adherent (supernatant) and adherent (trypsin/EDTA-treated) cells were counted using a Coulter counter (Coultronics). The percentage of adhesion is the number of adherent cells divided by the total number of cells recovered from each well.
Three-dimensional cultures
Immediately prior to the experiment, ice-cold Matrigel (300 ml) was poured into 1.9 cm 2 culture wells (4-well plates, Nunclon) and allowed to gel at room temperature or at 378C for 30 min. No dierences in gel formation were observed when using either temperature. Cells (75 000/0.5 ml) were seeded onto the gels and incubated in culture medium at 338C (IBE) or 378C (MAE) in a humidi®ed 5% CO 2 atmosphere for the indicated time. The culture medium was changed every 3 or 5 days during the length of the experiment. At the end of the experiment, cells were ®xed and stained (Di-Quick staining kit, Dade), and examined by light microscopy.
Reconstituted gels were also prepared on ice by mixing type I collagen and Matrigel. A collagen solution was prepared by mixing seven volumes of type I collagen (rat tail, UBI) with one volume of 106DMEM, one volume of DMEM-10% FCS and one volume of 22.2 g/l sodium bicarbonate. One volume of this collagen solution was mixed together with one volume of Matrigel and one volume of DMEM. This mixture was poured into 24-wells culture dishes (300 ml/well) and allowed to gel at 378C. After 15 min, a second layer was dispensed containing 500 cells/ 300 ml of collagen-Matrigel mixture. After gel formation, 0.5 ml of culture medium was added, containing or not 10 ng/ml FGF2. Medium culture was changed every 2 or 3 days during the length of the experiment. At the end of the experiment, cells were ®xed and stained using the staining solution II from the Di-Quick staining kit (Dade).
